Engineering human stellate cells for beta cell replacement therapy promotes in vivo recruitment of regulatory T cells

Type 1 diabetes (T1D) is an autoimmune disease characterized by destruction of pancreatic β cells. One of the promising therapeutic approaches in T1D is the transplantation of islets; however, it has serious limitations. To address these limitations, immunotherapeutic strategies have focused on rest...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mater Today Bio
Main Authors: Oran, D.C., Lokumcu, T., Inceoglu, Y., Akolpoglu, M.B., Albayrak, O., Bal, T., Kurtoglu, M., Erkan, M., Can, F., Bagci-Onder, T., Kizilel, S.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Full-Length Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7061575/
https://ncbi.nlm.nih.gov/pubmed/32159143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mtbio.2019.100006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados